Oncology
A new study published in Science Translational Medicine reveals why EGFR inhibitors, which are approved to treat cancers such as lung and colorectal cancer, cause severe skin side effects.
Specific gut bacteria can activate plant-derived compounds that protect against cancer, according to a study published in Nature Microbiology.
Certain fungi move from the gut to the pancreas, where they can trigger pancreatic cancer growth, according to a new study published in Nature.
The tumor microbiota could influence the pancreatic cancer survival, the 1st report to explore the effect of tumor bacteria on clinical outcomes claims.
Researchers have engineered bacteria that can colonize tumors and deliver immunotherapy drugs. The study was published in Nature Medicine.
"MIBIOC - The way of the microbiota in cancer" - IRCCS National Cancer Institute, Milan, 21-22th November 2019.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
Researchers from the University of Trento have found that specific changes in gut microbiota composition are associated with colorectal cancer.
Scientists may have just figured out how colibactin, a DNA-damaging molecule produced by certain strains of E. coli, contributes to colorectal cancer.
